BusinessAgile Therapeutics to Present Additional Phase 3 Data at the 2017 Annual Clinical and Scientific Meeting of the American Congress of Obstetricians and GynecologistsBy Nasdaq OMXMay 3, 2017, 8:15 PM UTC